See also this year's filing and all EDGAR filings for this company.
PDF Report 0000109657_2017_GT_Biopharma_Inc.pdf
Logs
warning | Missing logo | subcommand.report | {} |
info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0000109657')"} |
Graph
Absolute values for 0000109657, GT Biopharma Inc.
xvar | xval | |
---|---|---|
0 | AssetsCurrent | 21,000 |
1 | IntangibleAssetsNetIncludingGoodwill | 0 |
2 | PropertyPlantAndEquipmentNet | 4,000 |
3 | remainder_Assets | 0 |
4 | LiabilitiesCurrent | 18,949,000 |
5 | LiabilitiesNoncurrent | 0 |
6 | remainder_Liabilities | 0 |
7 | CostOfGoodsAndServicesSold | 0 |
8 | SellingGeneralAndAdministrativeExpense | 8,399,000 |
9 | ResearchAndDevelopmentExpense | 975,000 |
10 | remainder_Expenses | 0 |
11 | remainder_Revenues | 0 |
12 | remainder_NetIncome | 30,407,000 |
13 | remainder_ComprehensiveNetIncome | 0 |
yvar | yval | |
---|---|---|
0 | Assets | 25,000 |
1 | Liabilities | 18,949,000 |
2 | Expenses | 9,374,000 |
3 | Revenues | 0 |
4 | StockholdersEquity | -18,924,000 |
5 | NetIncome | 21,033,000 |
6 | ComprehensiveNetIncome | 21,033,000 |
7 | BaseVar | 29,377,500 |
8 | EconomicCapitalRatio | -1.21 |